Brigitte Jonczyk, Naturopath, Rastede, Germany
Fellow members of the Brügemann family, fellow bioresonance therapists,
Six years ago I took over a naturopathy practice specialising in bioresonance therapy. This practice has a history of over 30 years of bioresonance therapy. Today, we are working with 8 bioresonance devices including 3 BICOM BICOM optima® and 5 BICOM 2000 devices.
I am constantly discovering patients who have been diagnosed with “age-related macular degeneration”, so a few years ago I started to find out more about this widespread eye disease. Bioresonance therapy has meanwhile become a key feature of our therapy programs and is also used in the treatment of this condition.
Macular degeneration develops over many years, virtually without any symptoms. The end stage is characterised by a marked, rapid deterioration in eyesight, possibly culminating in total blindness. One promising treatment approach is based on a combination of conventional and complementary medicine. This can keep clinical symptoms at bay, especially at the start of this disease.
My presentation on this topic will focus solely on age-related macular degeneration (AMD). No reference will be made to macular degeneration with a different aetiology, such as severe short-sightedness (myopic macular degeneration), genetic and toxic causes, or macular degeneration due to the side effects of medicinal products (e.g. anti-rheumatic agents and many psycho pharmaceuticals). This kind of macular damage differs from AMD in terms of onset and subsequent development such that the therapeutic approaches outlined below simply cannot be applied. Complementary medicine offers two types of supportive therapy. The choice of treatment must always be considered for each specific case.
In Germany, over 2 million people suffer from this condition with the number of cases rising each year. The disease mostly develops around the age of 50, increasing exponentially thereafter. Nowadays, AMD is the main cause of blindness in the industrialised countries. It is responsible for 32% of new cases of blindness and 16% of glaucoma and diabetic retinopathy, respectively. Conventional treatment methods are only available for certain forms of wet AMD.
The term macular degeneration refers to a group of eye conditions affecting the Macula lutea (“the point of keenest vision”) – also known as the “yellow spot” of the retina and associated with a general loss of function in the tissue located in this area. Metabolism in this central area of the retina is particularly active. Degradation products are disposed of by the underlying layer of tissue – the so-called pigment epithelium. With advancing age, disorders can develop leading to deposits beneath the retina with a subsequent impact on function. This is known as “age-related (or senile) macular degeneration”, abbreviated to “AMD” or “ARMD”.
A distinction can be made between two types of macular degeneration – a dry form that advances very slowly and a wet, rapidly developing form. 85% of patients are affected by the dry form and approximately 15% by wet macular degeneration.
Both forms lead to blurring in the centre of the visual field, distorted vision, a dark spot or fading of colours. Since only the central area of the retina, i.e. the macula, is affected, the outer field of vision remains intact. This means that the patient can see a watch, for instance, but may not be able to see the exact time. Reading and facial recognition are the first visual functions to be affected.
An ophthalmologist should be consulted as soon as possible following the onset of mild symptoms such as distorted vision or loss of visual acuity.
Early diagnosis generally involves a test using a so-called Amsler grid. This simple aid is easy to use in practice and clearly highlights the phenomena outlined. Both eyes must be tested individually using this approach and it is important to cover up the other eye completely.
The disease can be detected very early thanks to modern ophthalmology. It involves the use amongst other things of high resolution fluorescence microscopic techniques to highlight the back of the eye in the micrometer range. This allows additional diagnosis-related information to be obtained. The time at which dry macular degeneration is diagnosed is important in order to introduce targeted holistic therapy as soon as possible. At any rate, this is my motto: Prevention is better than cure.
The holistic prophylactic approach is geared towards promoting the circulation, regeneration and reducing inflammatory influences throughout the body.
And what better treatment option could be more suited than bioresonance therapy!
Treatment measures include:
– Purging the tissue
– Elimination of environmental toxins
– Reduction in oxidative stress through the targeted use of micro nutrients and changing dietary habits (adequate fluid intake)
Dry macular degeneration and its causes
The dry (atrophic) form accounts for approximately 80% of cases but only 5 to 10% of AMD-induced loss of sight.
Dry AMD begins through the build-up of extracellular material beneath the retina (drusen) and metabolic products (lipofuscins) together with impaired choroidal circulation, culminating, at the advanced stage, in atrophy of the retinal pigment epithelium. The clinical advance is generally slow and insidious. As this frequently occurs below the point of keenest vision, it sometimes also leads to rapid loss of vision and clouding of the visual centre. This then manifests in the form of distorted vision and a gradual loss of visual acuity.
Causes of wet (exudative) macular degeneration
If the supply of oxygen, vitamins and other vital substances is depleted for prolonged periods, a messenger is triggered in the blood (VEGF = vascular endothelial growth factor, known as the angiogenesis factor). Its formation is stimulated by a change in the Bruch’s membrane and pigment layer. Furthermore, the number of drusen present and the ensuing inflammatory processes seem to have a crucial impact on the extent of the condition. The VEGF messenger instigates the formation of new vessels in an attempt to improve the circulation. Vessels, which are often invisible to the ophthalmologist, grow out from the perfused choroidea onto the macula. The Fovea centralis has no vessels because vessels in this region would disrupt free optical imaging. The newly formed vessels leak and are porous. Lymphatic fluid and blood flow into the retinal layers and force the nerve cells apart. Nerve tissue with its sparse connective tissue content is forced apart by the underlying drusen in the dry form of age-induced macular degeneration. Therefore fluid can spread relatively freely in this area. Swelling of the centre of the retina (so-called macular oedema) with disrupted impulse condition is the inevitable consequence. This process can occur within hours. The dry form has now developed into wet age-related macular degeneration.
Fig. 4: Comparison of intact retina (above), wet AMD and altered retina (below)
Key influencing factors are:
– Increasing exposure to sunlight
– Reduced performance of the pigment layer
– Depleted nutrient and vitamin supply
– Impaired circulation and calcification of the arteries
AGEs (Advanced Glycation End-products) pose a particular problem. These are nondegradable chemical compounds of protein and sugar. Glycosylation (technical term for the chemical reaction of sugar and protein) can occur in all tissues in the human body.
AGEs are associated with various ocular diseases (e.g. cataract, diseased retina and macular degeneration). High levels can be detected in lipofuscin deposits in the retinal pigment epithelium, in drusen and in Bruch’s membrane. In these regions, enzymes prevent the cell waste products from breaking down and trigger inflammatory reactions.
With reference to the specific problem of macular degeneration, bioresonance therapy allows us to remove waste from the pigment layer more effectively. This should allow the blood to flow more freely and vessel elasticity is improved. If possible, calcification is removed from the vessel walls and damaged eye cells are regenerated.
AGE enzymes prevent cell waste products from breaking down:
– Exposure to heavy metals
– Exposure to pesticides
– Vegetative dysregulation
– Acid-base balance
Regulating ocular circulation
Two extensive vascular networks ensure that the retina is thoroughly perfused (see Fig. 2).
The first network is supplied via the central retinal artery and the retinal vasculature, which branches off into the retina in the inner section of the eye. It passes quite closely to the macula but skirts the central section, the Fovea.
The second vascular network is the so-called choroidea. It supplies the retina from outside, thus largely compensating for the lack of vessels in the Fovea. The choroidea has a rich vascular network and the greatest blood flow in the body. Blood flow through the choroidea and retina is controlled in various ways.
Retinal vessels undergo auto-regulation whereby blood flow through the tissue is adjusted depending on the actual situation. The width of the vessels is governed by biochemical substances (e.g. histamine, prostaglandin, endothelin, etc.). Disruption of the auto-regulating function of the retinal vessels is currently being investigated in numerous studies since this auto-regulation process is impaired in many eye-related diseases. In contrast, the choroidea is governed by the vegetative nervous system. Stress and tension have a particularly negative effect on the circulation here since stress hormones can cause vessels to constrict and thus reduce circulation.
Therefore, it is essential that patients with age-related macular degeneration cope with their psychological situation in order to find ways of substantially reducing tension and stress on a daily basis. Moreover, bioresonance therapy can have an excellent impact on the vegetative nervous system and the auto-regulatory mechanisms.
Because of its highly active metabolic process, the retina and especially the macula react to the slightest change in circulation. Firstly, the macula does not receive an optimum supply of oxygen, vitamins and nutrients, and, secondly, the disposal of waste products is not sufficiently effective. Consequently, deposits of nonreusable , partly toxic substances develop in and beneath the pigment layer. These substances also develop when dead visual cells decompose. In increasing quantities, they disrupt the function of the pigment epithelial cells, possibly culminating in premature necrosis of the latter.
Given the complex relationships associated with the complicated metabolic processes of the retina, we can only hazard a guess as to the number of situations in which we can positively intervene. The overall condition of the body impacts more upon the health of our eyes than it does on any other organ.
Bioresonance therapy should be initiated in the dry stage of the disease. The holistic approach is essential in this respect. The aim and purpose of all these endeavours is to prevent the transition to the wet form altogether or to delay the latter for as long as possible.
A detailed, individual explanation is thus very important since many people still have so much visual acuity that they feel under no pressure to take preventive action to protect their health.
The latest research shows that age-related macular degeneration, like many other diseases, can be partly attributed to proinflammatory substances developing during metabolic processes.
The holistic approach recommended, namely to detoxify, purge and optimise metabolism, is directed towards reducing precisely these pro-inflammatory substances and is therefore highly appropriate as a form of therapy!
Tips including regular exercise, preferably outdoors, a balanced diet with many bioavailable basic substances and antioxidants , a healthy amount of sleep and the avoidance of stressful situations should also be mentioned to the patient in this context.
A daily intake of 1.5 – 2 litres of fluid will purge the basic system and should very much be seen as a detoxification measure in its own right.
The overall bio-energetic concept
The practical approach in our practice
1. The patient contacts us
2. We send out a form requesting a detailed medical history
3. The patient returns the questionnaire
4. We assess the medical history
Initial discussion and examination.
Bioenergetic examination with the biotensor:
1. Background contamination, e.g. milk, wheat and eggs
2. Candida albicans
3. Heavy metal contamination (cadmium, amalgam, palladium)
4. Post-vaccinal complications
5. Vital stress
6. Bacterial infection
7. Parasitic infestation
8. Chemical contamination (formaldehyde, cadmium, pesticides, etc.)
9. Food additives
10. Medication stress
Detection of metabolic weaknesses:
– Disruption of the acid-base balance
– Disruption of the vitamin balance
– Disruption of the mineral balance
– Disruption of the liver meridian
– Disruption of the gallbladder meridian
– Dysbacteria (intestinal flora)
– Disruption in the region of the intestinal flora (vit. B12 absorption)
– Disruption in the region of the gastric mucosa (intrinsic factor)
– Fermentation and decomposition
– Protein degradation substances and associated contamination
– Disruption in pancreatic metabolism
– Disruption in lipid metabolism
– Disruption in carbohydrate metabolism
– Disruption in protein metabolism
– Stress/contamination due to vaccinations/pathogens/metals
– Impaired elimination
– Viral stresses
– Bacterial infection
– Heavy metal contamination.
In my medical history, particular attention should be paid to the following disorders. Everything related to macular degeneration:
– Hypertension or fluctuating blood pressure
– Heart attack and/or stroke, also in family members/relatives
– Sudden loss of hearing, tinnitus
– Arterial calcification and/or occlusion of the carotid artery
– Poor circulation in the extremities (cold feet and hands)
– Diabetes mellitus
The following are also of interest:
– Eating habits
– Leisure activities
– Handling environmental toxins
– Social milieu
– Mental constitution
– Unresolved mental conflicts
– Built-up aggression
– Persistent stressful situations
– Smoking, including passive smoking, alcohol consumption
– Fluid intake
– Medication intake
The following steps must be adapted to suit each patient and his/her situation.
1. Basic therapy
Following conductance test, to balance energy and fine tune the body
2. Eliminate therapy blocks
Spinal blocks, especially C2, frequently coupled with eye diseases (possible indication for a manual therapeutic approach)
Geopathy compensation 700.3
Elimination of scar interference 910.3
Releasing blocks 951.1
Medication block 847.0
Tissue blocks 701.4
Blocks, releasing (energetically) 915.2
Temporomandibular joint correction 530.2
Disturbed laterality 535.2
Mesenchyma therapy 433.1
Regulation, general (stress reduction, physical) 3084.0
Hyoid bone correction 530.5
Chakras are very important and effective in the treatment of agerelated macular degeneration.
Testing and treatment are described in the treatment manuals and should be introduced early on as an independent treatment strategy.
3. Meridian/organ-related follow-up therapies
Five element theory
The eye is part of the liver meridian. Eye diseases can thus develop in the liver meridian or in the region of the connected gallbladder meridian.
Disruptive elements may, for instance, include hip joint problems, liver diseases or root inflammation of a canine tooth, plus scars in the path of the affected meridian or non-tolerated materials in prostheses (hip and knee joint prostheses, dental fillings).
On a psychological level, pent-up aggression and rage damage the gallbladder meridian and can thus indirectly cause eye problems.
These blocks can also be effectively removed with bioresonance therapy.
Based on test readings of the eliminating organs:
– Stabilising and opening of the eliminating organs
– Programs 200 – 391
– Test out time and meridian; see the test kit manual (Combined Test Technique)
4. Indication-related follow-up therapies
– Lymph activation
– Liver detoxification
– Kidney stimulation
– Mycosis therapy
Pathogenic fungal colonisation of the gastrointestinal tract with Candida albicans leads to extensive “slagging” of the basic substance, contaminates the liver and disrupts the intestine-related immune system. It should therefore be treated.
Over-acidity is an important trigger factor in “slagging” the basic system. Amongst other things it hampers the elimination of environmental toxins, heavy metals and many hazardous metabolic products.
These relationships are very well known. Therefore I won’t discuss this any further as regulation of the acid-base balance should be part and parcel of basic patient treatment.
Testing the blood
Poor circulation and a disrupted blood flow are of crucial significance in macular degeneration.
It is also important to test for the metabolic marker, homocysteine. Increased levels of this marker indicate that the patient is more prone to develop macular degeneration. Folic acid, vitamin B6 and vitamin B12 deficiency can cause elevated homocysteine levels. Furthermore, numerous drugs such as lipid-lowering agents, gastric medication (e.g. proton pump inhibitors), the “pill”, asthma medication, anti-diabetic agents as well as caffeine, alcohol and nicotine can have a negative impact on homocysteine levels.
Attempts should be made to find alternative herbal remedies or homocysteine levels should be lowered with appropriate vitamins.
5. Stabilising programs
– Energetic stabilising
– Metabolic programs
– Vitalising programs
BICOM BICOM optima®
– Start by selecting program category 1 – 3 “Energetic stabilising”
– Carry out individual tests for each patient
Orthomolecular medicine in ophthalmology
Certain orthomolecular substances and vitamins can protect the macula from UV light, improve the elimination of metabolic products in the pigment layer and make the blood flow more freely.
These substances can also help to reduce vessel wall deposits, regenerate visual cells and much more.
Here is a list of substances for orthomolecular therapy:
Omega-3 fatty acids 1 – 2 g daily, long-term
As regards macular degeneration, apart from the important anti-inflammatory and antioxidative effects, a sufficient intake of omega 3 fatty acids reduces the formation of the harmful substance lipofuscin and improves its decomposition in the pigment epithelium. Lipofuscin, often termed the “aging pigment” is a yellowish brown, cross-linked aggregate comprising oxidised protein and lipid clusters. In age-related macular degeneration, an almost linear accumulation of lipofuscin occurs in RPE cells1,with advancing age. This impairs the function and life-span of the cells, culminating in cell death.
Furthermore, a reduction in the sensitivity of retinal cells to the VEGF growth factor was observed following an increased intake of omega 3 fatty acids. This has resulted in a longer lifespan for visual cells, particularly in areas with impaired blood flow.
Most of these positive effects of omega 3 fatty acids can be attributed to optimisation of the cell membrane function. They are also vital in nutrition and replacement therapy, and not only in the case of macular degeneration.
Ginkgo Biloba extract 100 – 200 mg daily, long-term
The positive effects of ginkgo tree leaf extracts (Ginkgo biloba folium) have been thoroughly tested experimentally and clinically. They have proved to be effective particularly in the cranial and retinal circulation. Regular intake enhances the circulation in the smallest of vessels (so- 1 RPE = retinal pigment epithelium called microcirculation), improves blood flow properties and protects the retinal cells against oxidative stress.
6. Elimination therapy (pathogenic stresses)
– Generally Ai, patient no longer at the input
– Test out time and amplification
– Eliminating organs must always be free
Contamination with heavy metals
Recent tests point to a build-up (accumulation) of cadmium in the choroidea and retina, especially in the pigment layer. Here, the heavy metal has a negative effect on zinc metabolism. On the one hand this causes the retinal cells to age more quickly with an impact on function and, on the other hand, disruption to the process of converting vitamin A to visual purple.
Both processes can cause or exacerbate macular degeneration. Heavy metals such as mercury (amalgam), palladium, etc. should consequently be eliminated.
Contamination with pesticides
Studies conducted in Japan, India and the USA have meanwhile highlighted a clear link between the absorption of pesticides and the onset of macular degeneration in humans.
Consequently contact with pesticides should be avoided in all cases, both in terms of food intake and use in the home.
• Timber preservatives and insect sprays contain similar compounds
• Medicines such as
– Cytostatic agents
All pathogenic substances that contaminate the body should be eliminated after testing, including the main allergens.
7. Stabilising of patients’ eyes
Input cup: blood, saliva, tear fluid
Output cup: BICOM® minerals
Storage device: chip
Input: flexible eye applicators connected with 2 black cables
Output: modulation mat on back
Attach the chip to the thymus and drink 6 drops of BICOM® minerals 3 times a day, depending on symptoms.
Dry macular degeneration
Standard treatment for dry macular degeneration using the flexible eye applicator or with the button applicator for individual eye treatment.
We have found the round adhesive applicators to be particularly beneficial in our practice.
They are attached to the patient’s closed eyelid without previously removing any grease from the upper lid. Connect the push button adapter of the special cable before attaching and fixing the special cable to the patient’s forehead, so as to avoid any tensile forces acting on the adhesive applicator.
Various programs have been used based on our experience with our numerous AMD patients.
The programs highlighted in bold were those used mostly frequently for this indication and have been shown to be beneficial.
In cases where one eye is affected by wet macula degeneration, no measures to promote blood flow should be performed on this eye.
In such cases the eyes can be treated separately with a button applicator.
Substance complexes, standard macular degeneration
Substance complexes which can also be used after testing are shown in the Annex.
Channel 2: Stabilising ampoules from the 5-element test set
Earth: Organ degeneration, sensory organs, metabolism
Metal: Large intestine
Water: Kidneys, lymph, teeth
Wood: Liver, gallbladder and bile ducts, Yin-Yang balance, chemical contamination, impaired elimination, stressed interstitial cell tissue, acute or chronic contamination
Fire: Circulation, small intestine
Organ preparations from the vitOrgan or Heel companies can also run through channel 2.
Neurophysiology of the central visual system
Direct projection from the retina to the primary visual cortex is effected via glial cells. These specialised neurons can be treated particularly effectively using the low deep frequencies and other brainstimulating treatment programs.
The brain is involved in the low deep frequency therapy because the eyes and certain centres of the brain are closely connected and influence one another continuously.
The brain is the intelligent control centre for healthy eyes. It controls the metabolism, circulation and nerve function of the eyes.
The low deep frequency treatment specifically activates the macula via the visual centre in the brain and can be used in both dry and wet macular degeneration. Low deep frequencies should always be incorporated in treatment wherever possible.
Potential treatment programs are considered in the Annex and can be individually tested for each patient.
Low deep frequencies used locally in the eye in the case of macular degeneration
BICOM BICOM optima®:
– Programs 3
– Start by selecting category 1 (low deep frequencies)
– Carry out individual tests for each patient
The following programs are used to stimulate the visual cortex as well as the neurons in the optic tract and visual cortex:
Vegetative dysregulation 960.4
Autoregulation 432.1, 827.4, 281.4
CNS disorders 940.2
Activation right side of the brain 571.0
Activation left side of the brain 572.0
Laterality disorder 535.2
Age-related macular degeneration is a disease in which active patient cooperation is essential.
Patients with macular degeneration are treated every week in our practice until all risk factors have been eliminated. Local eye treatment is also carried out in every case. Possible treatment programs are tested out.
A substance complex always runs with stabilising ampoules from the 5-element kit through channel 2.
This is continued by treatments every 3 – 4 weeks and also encompasses general detoxifying treatments.
The information leaflet that can be accessed via our Homepage is an important reference for our AMD patients.
Successful treatment of AMD using the BICOM® method
The pace at which patients respond to bioresonance therapy varies. Therefore the speed of the reaction will also differ from one patient to the next.
Based on the number of patients we have treated to date, we can say that bioresonance therapy constitutes comprehensive treatment for AMD and offers numerous additional healing options. Early onset of treatment at the dry AMD stage is vital for therapeutic success. Intervention at this stage can prevent the transition to wet macular degeneration or delay this for a considerable period of time. We aim to treat patients holistically in order to improve and stabilise eyesight in the long term without triggering any risks or side effects. As therapists, we are often asked in our
practices to develop vision, recognise risk factors, inform patients accordingly and introduce treatment as early as possible.
Your patients will thank you for it. I hope that this presentation on AMD has helped you see the therapy benefits of this approach. I wish you and your patients every success.
Stay healthy in body and soul, and have a safe journey home.
All the best,
Literature and image/photo credits are available at email@example.com.
BICOM BICOM optima®
Programs 2: Individual therapy low deep frequencies
3003.0 Increase powers of resistance
3079.0 Renal function impairment 2nd prog.
3012.0 Excessive eyestrain
3080.0 Renal regulation
3011.0 Eye problems
3084.0 Regulation, general
3017.0 Releasing blocks
3086.0 Oxygen regulation
3019.0 Blood pressure too high
3089.0 Mucosal regulation
3020.0 Blood pressure regulation
3093.0 Shock treatment, acute
3021.0 Improve blood count
3094.0 Shock treatment 1st program
3022.0 Regulate blood circulation
3095.0 Shock treatment 2nd program
3031.0 Regulate circulation
3100.0 Poor vision
3032.0 Circulatory disorders
3106.0 Metabolic disorder 1st program
3036.0 Regulating detoxification
3107.0 Metabolic disorder 2nd program
3108.0 Thymus activation
3040.0 Tissue regeneration
3053.0 Regulate immune system
3054.0 Problems with mandibular joint
3061.0 Stimulating cardiovascular system
3062.0 Circulatory debility, vertigo?
3063.0 liver detoxification
3064.0 Liver/gallbladder regulation
3067.0 Tonsillitis, sore throat
3074.0 Nerve regulation 1st program
3075.0 Nerve regulation 2nd program
3077.0 Stressed nervous system
3078.0 Renal functional impairment
BICOM BICOM optima®